Camson Bio Technologies Ltd - Stock Valuation and Financial Performance

BSE: 538858 | NSE: | Agriculture | Small Cap

Camson Bio Share Price

3.31 0.00 0.00%
as on 11-May'20 18:01

DeciZen - make an informed investing decision on Camson Bio

M-Cap below 100cr DeciZen not available

Camson Bio Technologies stock performance -

mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
9.9 Cr.
52-wk low:
3.3
52-wk high:
3.3

Is Camson Bio Technologies Ltd. an attractive stock to invest in?

1. Is Camson Bio Technologies Ltd. a good quality company?

Data is not available for this company.

2. Is Camson Bio Technologies Ltd. undervalued or overvalued?

The key valuation ratios of Camson Bio Technologies Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

3. Is Camson Bio Technologies Ltd. a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Camson Bio Technologies Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Camson Bio:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19TTM
ROCE % 23.5%24%17.1%14.4%7.9%2.1%-15.2%-13.6%-6.3%-20.1%-
Value Creation
Index
0.70.70.20.0-0.4-0.9-2.1-2.0-1.5-2.4-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 8098.711212014616925.410.419.355
Sales YoY Gr.-23.5%13.7%6.6%21.8%16.3%-85%-59.3%86.6%-74.2%-
Adj EPS 8.512.111.412.76.31-12.6-7.7-3.7-7.3-8.4
YoY Gr.-42.7%-5.9%11%-50.8%-83.7%-1336.3%NANANA-
BVPS (₹) 43.257.969.380.880.88834.825.722.214.912.4
Adj Net
Profit
13.72220.72315.83.1-37.8-23.2-11.2-21.9-25
Cash Flow from Ops. 10.5-1.910.2-13.5-14.714.1-104.61.80-
Debt/CF from Ops. 0.1-0.61.2-3-2.72.6-4.710.126.7554260.7-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -26.5%-49.1%-41.9%-74.2%
Adj EPS -198.3%-203.2%NANA
BVPS-11.2%-28.7%-24.6%-32.9%
Share Price -24.6% -13.7% - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19TTM
Return on
Equity %
23.724.117.8168.11.3-20.5-25.6-15.6-39.3-61.4
Op. Profit
Mgn %
20.322.819.623.61710.9-56.6-127.70.2-329.4-439.3
Net Profit
Mgn %
17.122.318.519.210.81.8-148.9-224.1-58.2-440-516.8
Debt to
Equity
000.10.30.20.10.50.60.71.1-
Working Cap
Days
1422262973543853821,7451,8718993,0571,678
Cash Conv.
Cycle
1251882372702752991,3566064832,737-1,110

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Camson Bio Technologies Ltd.

Standalone Consolidated
TTM EPS (₹) -8.4 -3.7
TTM Sales (₹ Cr.) 4.9 19.3
BVPS (₹.) 12.4 22.2
Reserves (₹ Cr.) 7 37
P/BV 0.27 0.15
PE 0.00 0.00
From the Market
52 Week Low / High (₹) 3.31 / 3.31
All Time Low / High (₹) 3.31 / 252.00
Market Cap (₹ Cr.) 9.9
Equity (₹ Cr.) 30
Face Value (₹) 10
Industry PE 22.6

Management X-Ray of Camson Bio:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *26.4926.4926.4926.4926.4926.4926.4926.4926.4926.49
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Camson Bio

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Sales79.9898.74112.24119.61145.63169.3825.4010.3519.314.98
Operating Expenses 63.7676.2390.2991.44120.95150.8439.7823.5619.2821.37
Manufacturing Costs16.4258.1540.5144.9923.9336.515.351.620.580.33
Material Costs14.43-18.814.2412.4348.6448.974.842.487.7015.18
Employee Cost 2.094.405.087.078.5712.949.925.954.212.11
Other Costs 30.8232.4940.4626.9539.8152.4319.6713.526.793.74
Operating Profit 16.2222.5121.9528.1724.6818.54-14.38-13.210.03-16.39
Operating Profit Margin (%) 20.3%22.8%19.6%23.6%16.9%10.9%-56.6%-127.0%0.2%-329.0%
Other Income 0.350.940.490.300.536.351.163.941.303.20
Interest 0.200.140.362.013.874.094.996.515.361.14
Depreciation 1.660.921.643.355.1113.4021.727.447.196.97
Exceptional Items 0000-3.5600000
Profit Before Tax 14.7122.3920.4523.1112.677.40-39.93-23.22-11.22-21.31
Tax 1.060.38-0.280.10-0.604.32-2.09-0.1700.59
Profit After Tax 13.6622.0120.7223.0113.273.08-37.83-23.05-11.22-21.90
PAT Margin (%) 17.1%22.3%18.5%19.2%9.1%1.8%-148.0%-222.0%-58.1%-440.0%
Adjusted EPS (₹)8.512.111.412.75.31.0-12.6-7.7-3.7-7.3
Dividend Payout Ratio (%)12%8%9%8%19%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19

Equity and Liabilities

Shareholders Fund 69.37104.88125.59146.50203.86263.98104.2477.0366.6644.75
Share Capital 16.0518.1318.1318.1325.233030303030
Reserves 53.3286.75107.46128.37178.63233.9874.2447.0336.6614.75
Minority Interest0000000000
Debt10.9912.3938.4237.0736.6446.6945.8748.7049.82
Long Term Debt10.192.5315.9111.954.949.498.429.8111.38
Short Term Debt00.809.8622.5125.1231.7037.2037.4538.8838.44
Trade Payables0.4113.817.502.763.5210.376.867.518.287.62
Others Liabilities 14.7011.567.6828.9037.8112.651315.5116.7218.74
Total Liabilities 85.49131.25153.17216.58282.26323.65170.79145.92140.36120.92

Fixed Assets

Gross Block35.4831.2640.9288.06124.32166.51151.41147.89148.98148.98
Accumulated Depreciation6.614.656.299.6414.7227.9634.5741.6048.7955.76
Net Fixed Assets28.8726.6134.6378.42109.60138.55116.83106.29100.1993.22
CWIP 5.5211.1622.1200.0100000
Investments 0.844.350.010.010.010.015.983.403.403.40
Inventories22.3042.7240.0139.5639.9825.349.2411.9240.3525.88
Trade Receivables11.7342.3646.9364.0684.01145.4916.603.725.116.57
Cash Equivalents 15.031.940.861.681.921.030.300.230.090.06
Others Assets1.192.108.6132.8546.7313.2421.8420.36-8.78-8.21
Total Assets 85.49131.25153.17216.58282.26323.65170.79145.92140.36120.92

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Cash Flow From Operating Activity 10.45-1.8510.15-13.48-14.6714.12-9.994.561.830
PBT 16.2122.3920.4523.1112.675.05-39.93-27.37-11.05-21.90
Adjustment 0.520.871.768.7117.2223.5626.3722.1511.594.93
Changes in Working Capital -6.23-24.73-12.06-45.29-45.14-14.994.29.841.2816.96
Tax Paid -0.05-0.38000.580.50-0.63-0.0500
Cash Flow From Investing Activity -18.56-20.83-20.18-25.02-36.31-43.315.292.720.73-0.01
Capex -17.93-17.49-20.62-25.02-36.32-43.3211.212.69-0.41-0.01
Net Investments -0.83-3.510000-5.97000
Others 0.200.170.44000.010.050.031.150
Cash Flow From Financing Activity 21.999.608.9539.3251.2328.304.23-7.33-2.53-0.02
Net Proceeds from Shares 17.6315.600044.1431.890000
Net Proceeds from Borrowing 0000000000
Interest Paid -0.03-0.02-0.36-1.80-3.31-3.96-4.99-6.51-5.36-1.14
Dividend Paid -1.60-1.870-2.10-2.1200000
Others 6-4.119.3143.2212.520.379.22-0.822.831.12
Net Cash Flow 13.88-13.09-1.080.820.24-0.89-0.47-0.040.03-0.03
PARTICULARSMar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Ratios
ROE (%)24.9725.2617.9816.917.581.32-20.55-25.44-15.61-39.31
ROCE (%)25.3624.4216.9114.777.064.05-15.45-12.18-4.92-19.21
Asset Turnover Ratio1.210.910.790.650.580.560.10.070.130.04
PAT to CFO Conversion(x)0.77-0.080.49-0.59-1.114.58N/AN/AN/AN/A
Working Capital Days
Receivable Days431001451691862471,16435883429
Inventory Days85120135121100702483734942,429
Payable Days18-13891815124526501,060374191

Camson Bio Technologies Ltd Stock News

Camson Bio Technologies Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Camson Bio on 11-May-2020 18:01 is ₹3.31.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 11-May-2020 18:01 the market cap of Camson Bio stood at ₹9.93.
The latest P/E ratio of Camson Bio as of 11-May-2020 18:01 is 0.00.
The latest P/B ratio of Camson Bio as of 11-May-2020 18:01 is 0.27.
The 52-week high of Camson Bio is ₹3.31 and the 52-week low is ₹3.31.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Camson Bio is ₹4.87 ( Cr.) .

About Camson Bio Technologies Ltd

Camson, incorporated in 1993 is India's first wholly integrated Agriculture Biotechnology, is based at Bangalore, garden city of India. It became a Public Company in 1995. Camson has been promoted by technocrats with vast relevant experience. Its Vision is to create a healthy and disease free society by providing safe food. This vision forms the guiding beacon of Camson in its pursuit for wholesome goodness in agriculture and aims at being world class manufacture of Biotechnology products

The Company has a strong presence in the Indian market and has unique research and intellectual proprietary which gives the Company an edge over others. Its proprietary technology platform consists of microorganism database, superior proprietary seeds germplasm, screening technology, biocides, biofertilisers and hybrid seeds.

Camson has developed many unique biocides for plant protection and hybrid seeds for improved productivity. Their superior technology in crop transformation and functional genomics has helped in developing new products which are first of its kind in the country.

The infrastructure set up of the Company is at Bangalore North. The set up provides for a total composite production. It is State-of-the-art and spread over 20 acres of land. This affords a high level of space for multi-product production, simultaneously. The Company constantly upgrades its production facilities to keep pace with the increased demand for its products as also for producing a wider range of products pursuant to the success achieved on its research front.

Product range of the company includes:

  • Bio Fungicides
  • Bio Insecticides
  • Bio Stimulants
  • Bio Fertilisers
  • Hybrid Seeds

Achievements/ recognition:

  • Camson Bio Technologies has been recognized, for the second year in succession, as one of the fastest growing technology companies and placed at 17th position, in the Technology 50 India 2008 programme conducted by Deloitte Touche Tohmatsu, Asia Pacific.
  • Camson was declared a Stellar performer for the second year in a row under Technology Fast 500 Asia Pacific Ranking and CEO Survey 2008, obtaining 131st rank out of 500 companies identified by Deloitte.
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.